The UK’s National Institute for Health and Clinical Excellence (NICE) has issued new guidelines on the management of cancers of unknown primary origin (CUP), with the aim of better harnessing new diagnostic technologies and treatments. The initiative sought to address the ...
Please Login to read the full article.
